Envista Holdings Corporation
NVST
$26.66
+5.42%
Envista Holdings Corporation is a dental products company operating in the Healthcare sector's Medical Equipment & Services industry. It is a global leader with a diversified portfolio of dental consumables, equipment, and services, primarily driven by its high-margin Specialty Products & Technologies segment.…
NVST
Envista Holdings Corporation
$26.66
Investment Opinion: Should I buy NVST Today?
Based on a synthesis of the available data, the objective assessment for NVST is a Hold. The investment case is bifurcated: the forward valuation (P/E of 16.2) appears reasonable if the company can achieve analyst EPS estimates near $1.89, and its financial health is solid. However, this is counterbalanced by highly inconsistent historical profitability and weak operational returns, which justify the market's current skepticism and high short interest. Investors may want to wait for more consistent quarterly earnings execution before establishing a new position.
Sign up to view all
NVST 12-Month Price Forecast
The outlook is balanced. The path to a higher stock price depends entirely on translating strong sales and cash flow into reliable earnings. The wide gap between trailing and forward P/E underscores this transition risk. The base case of range-bound trading is most likely.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Envista Holdings Corporation's 12-month outlook, with a consensus price target around $34.66 and implied upside of +30.0% versus the current price.
Average Target
$34.66
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$21 - $35
Analyst target range
No sufficient analyst coverage available. The provided data includes recent rating actions from several firms but does not contain a consensus target price or a detailed ratings distribution summary.
Bulls vs Bears: NVST Investment Factors
Envista presents a mixed picture. Bullish factors include strong revenue growth, solid cash flow, and a reasonable forward valuation. However, these are countered by inconsistent profitability, weak operational returns, and recent technical weakness. The stock appears to be in a consolidation phase after a strong run.
Bullish
- Strong Revenue Growth: Q4 2025 revenue grew 15% YoY, indicating solid top-line momentum.
- Robust Free Cash Flow: Generated $230M in TTM FCF, supporting financial flexibility.
- Healthy Balance Sheet: Current ratio of 2.38 and manageable 51% debt-to-equity.
- Attractive Forward P/E: Forward P/E of 16.2 is reasonable based on analyst EPS estimates.
Bearish
- Inconsistent Profitability: Net income swings from large loss to small profit, margin only 1.7%.
- Poor Return Metrics: Low ROE (1.56%) and ROA (2.78%) signal inefficient capital use.
- High Short Interest: Short ratio of 2.84 indicates significant market skepticism.
- Recent Price Weakness: Stock down 13% in past month, underperforming the S&P 500.
NVST Technical Analysis
The stock has demonstrated significant volatility and a strong overall uptrend over the past six months, rising from approximately $20.57 in early October 2025 to $25.37 as of March 31, 2026, representing a 23.3% gain. Short-term performance has been mixed, with a 16.9% gain over the last three months but a sharp 13.1% decline over the past month, indicating recent profit-taking or sector weakness. The current price of $25.37 sits near the middle of its 52-week range ($14.22 to $30.42), having retreated from a peak near $30 in February 2026, suggesting the stock is consolidating after a strong rally.
Beta
0.98
0.98x market volatility
Max Drawdown
-20.7%
Largest decline past year
52-Week Range
$14-$30
Price range past year
Annual Return
+80.6%
Cumulative gain past year
| Period | NVST Return | S&P 500 |
|---|---|---|
| 1m | -0.1% | -0.3% |
| 3m | +12.9% | -2.0% |
| 6m | +39.9% | +3.5% |
| 1y | +80.6% | +36.2% |
| ytd | +22.9% | -0.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
NVST Fundamental Analysis
Revenue growth has been positive, with Q4 2025 revenue of $750.6 million showing a 14.96% year-over-year increase. Profitability has been inconsistent, with net income swinging from a $30.3 million loss in Q3 2025 to a $32.9 million profit in Q4 2025, resulting in a trailing net margin of just 1.73%. Financial health appears solid with a manageable debt-to-equity ratio of 51.43% and a strong current ratio of 2.38, supported by robust free cash flow generation of $230.4 million over the trailing twelve months. Operational efficiency metrics are currently weak, with a low Return on Equity (ROE) of 1.56% and a Return on Assets (ROA) of 2.78%, indicating challenges in generating profits from its asset base.
Quarterly Revenue
$750600000.0B
2025-12
Revenue YoY Growth
+0.14%
YoY Comparison
Gross Margin
+0.55%
Latest Quarter
Free Cash Flow
$230400000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is NVST Overvalued?
Given the company's positive but very low net income, the trailing Price-to-Earnings (P/E) ratio is extremely high at 90.6, which is not a meaningful valuation metric at this profit level. A more appropriate metric is the Price-to-Sales (P/S) ratio of 1.53 or the Enterprise Value-to-Sales (EV/Sales) ratio of 1.67, which reflect the market's valuation of its top-line revenue. Data for a direct peer comparison with industry averages is not available in the provided inputs.
PE
77.6x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -28x~693x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.1x
Enterprise Value Multiple
Investment Risk Disclosure
The primary financial risk is the company's inconsistent profitability, as evidenced by the swing from a $30.3 million loss in Q3 2025 to a $32.9 million profit in Q4 2025. This volatility makes earnings difficult to predict and results in a very high trailing P/E ratio, indicating the market's skepticism about sustainable bottom-line growth. The low ROE and ROA further highlight operational inefficiency risks.
Market and sentiment risks are also notable. The stock's high short interest (ratio of 2.84) suggests a significant portion of the market is betting on a decline. Furthermore, the stock has recently underperformed the broader market, falling 13.1% over the past month compared to the S&P 500's 5.25% decline, indicating potential sector-specific headwinds or profit-taking after its strong rally. The lack of a clear consensus analyst target price adds to the uncertainty surrounding near-term valuation.
While the company's balance sheet is healthy with strong liquidity, the core risk remains its ability to translate solid revenue growth and high gross margins into consistent and meaningful net profits for shareholders.
FAQ
The key risks are: 1) Earnings Volatility: Inconsistent quarterly profits, as seen in swings from loss to profit. 2) Operational Inefficiency: Very low Return on Equity (1.56%) and Return on Assets (2.78%). 3) Market Sentiment: High short interest (ratio 2.84) indicates skepticism. 4) Sector/Technical: Recent 13% monthly decline underperforming the market suggests ongoing weakness.
The 12-month outlook is for range-bound trading with a neutral bias. The base case (50% probability) sees a price range of $24-$28, assuming the company meets revenue and EPS estimates. A bull case (30%) could see a retest of the $30-$33 range if profitability improves markedly. A bear case (20%) risks a pullback towards $18-$22 if earnings disappoint.
NVST's valuation sends mixed signals. The extremely high trailing P/E of 90.6 suggests overvaluation based on current very low earnings. However, the more relevant forward P/E of 16.2, based on analyst estimates, and a P/S ratio of 1.53 appear reasonable for a company with its growth profile. The stock is fairly valued if future earnings materialize as expected, but risky if they do not.
Based on current data, NVST is rated a Hold. While its forward P/E of 16.2 is reasonable and revenue grew 15% YoY, the stock carries significant risk due to inconsistent profitability (net margin of 1.7%) and high short interest. It may be a good buy only for investors who are confident the company can achieve its estimated EPS of $1.89 and improve its operational returns.
NVST is more suitable for a patient, long-term investor who believes in the company's multi-year turnaround towards consistent profitability. The stock's volatility and execution risk make it a poor candidate for short-term trading. Long-term holders are betting on management's ability to fix operational inefficiencies and leverage its strong market position and cash flow.